Академический Документы
Профессиональный Документы
Культура Документы
Department of Pharmacology, Joan C. Edwards School of Medicine, Marshall University, 1542 Spring Valley Drive,
Huntington, WV 25704-9388, USA
b
Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA
c
Affinity Labeling Technologies, Inc., Lexington, KY 40508, USA
Received 6 December 2004
Abstract
Environmental exposure to mercurials continues to be a public health issue due to their deleterious effects on immune,
renal and neurological function. Recently the safety of thimerosal, an ethyl mercury-containing preservative used in
vaccines, has been questioned due to exposure of infants during immunization. Mercurials have been reported to cause
apoptosis in cultured neurons; however, the signaling pathways resulting in cell death have not been well characterized.
Therefore, the objective of this study was to identify the mode of cell death in an in vitro model of thimerosal-induced
neurotoxicity, and more specifically, to elucidate signaling pathways which might serve as pharmacological targets.
Within 2 h of thimerosal exposure (5 mM) to the human neuroblastoma cell line, SK-N-SH, morphological changes,
including membrane alterations and cell shrinkage, were observed. Cell viability, assessed by measurement of lactate
dehydrogenase (LDH) activity in the medium, as well as the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) assay, showed a time- and concentration-dependent decrease in cell survival upon thimerosal exposure.
In cells treated for 24 h with thimerosal, fluorescence microscopy indicated cells undergoing both apoptosis and oncosis/
necrosis. To identify the apoptotic pathway associated with thimerosal-mediated cell death, we first evaluated the
mitochondrial cascade, as both inorganic and organic mercurials have been reported to accumulate in the organelle.
Cytochrome c was shown to leak from the mitochondria, followed by caspase 9 cleavage within 8 h of treatment. In
addition, poly(ADP-ribose) polymerase (PARP) was cleaved to form a 85 kDa fragment following maximal caspase 3
activation at 24 h. Taken together these findings suggest deleterious effects on the cytoarchitecture by thimerosal and
initiation of mitochondrial-mediated apoptosis.
INTRODUCTION
Thimerosal (thiomersal, merthiolate, sodium ethylmercury thiosalicylate), an ethyl mercury-containing
* Corresponding author. Tel.: +1 304 696 7314;
fax: +1 304 696 7391.
E-mail address: kiningham@marshall.edu (K.K. Kiningham).
0161-813X/$ see front matter # 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.neuro.2005.03.008
DTD 5
mercury has increased among infants, whose developing nervous systems are vulnerable to mercurial toxicity. Following a report by Ball et al. (2001),
suggesting that cumulative levels of mercury from
vaccinations during the first 6 months of life may
exceed EPA guidelines, efforts have been made to
minimize exposure to thimerosal. While removed from
most pediatric vaccines, thimerosal is still used in
influenza vaccinations that are recommended for
young children, ages 623 months, as well as pregnant
women. Furthermore, many vaccines given to children
in developing countries still contain thimerosal.
Acute effects resulting from thimerosal exposure
include, but are not limited to, hypersensitivity reactions, nephro- and neurotoxicity (Ball et al., 2001).
Using an autoimmune disease-sensitive murine model
(SJL/J), Hornig et al. (2004) reported that genetic
influences may play a role in thimerosal-induced neurotoxicity. Thimerosal-containing ophthalmic medications, when applied topically, lead to mercury
accumulation within the brain (Gasset et al., 1975).
In addition, an increase in inorganic mercury has been
observed in the brains of monkeys following daily
administration of thimerosal (Blair et al., 1975), and
also in the brains of mice following a single injection of
thimerosal (Harry et al., 2004). These findings may be
explained by the fact that organic mercurials can
undergo biotransformation reactions resulting in accumulation of inorganic mercury in the central nervous
system (CNS) (Norseth and Clarkson, 1970; Friberg
and Mottet, 1989; Suda and Takahashi, 1991). While
methyl mercury has a half-life of several days or weeks
in the human brain, the half-life of inorganic mercury
has been estimated to exceed 20 years (Sugita, 1978;
Aschner and Aschner, 1990). Ethyl and methyl mercury distribute similarly upon initial exposure; however, entry into the CNS is thought to occur faster with
methyl mercury as passage across the blood brain
barrier involves an active, rather than a passive, transport process.
Mercuric chloride (HgCl2) and methyl mercuric
chloride (MeHgCl) cause apoptosis in cultured neurons
and astrocytes (Kunimoto, 1994; Monnet-Tschudi,
1998); however, the signaling pathways resulting in
apoptosis have not been clearly elucidated in cells of
either neuronal or glial origin. In vivo studies utilizing
Wistar rats show that MeHg intoxication results in
apoptotic degeneration of cerebellar granule cells characterized by ultrastructural and DNA fragmentation
analysis; however, specific cellular mediators involved
in the programmed cell death pathway have not been
identified (Nagashima et al., 1996).
Exposure limits for thimerosal, set by the Environmental Protection Agency, are based upon prenatal
exposure to methyl mercury rather than postnatal
exposure to ethyl mercury. Therefore, our objective
was to determine if thimerosal could induce cell death
in an in vitro system consistent with pediatric exposure. We chose to address the question in a model
characterized by an immature neuronal cell type,
resembling the developing nervous system, in order
to define the mode (apoptosis versus necrosis) and
mechanism (mitochondrial dependent versus independent) of thimerosal-mediated cell death. Since
limited studies have been conducted to test actual
mercury levels in infants immediately following
administration of thimerosal-containing vaccines,
we used a range of concentrations to conduct
mechanistic studies in our model. Magos (2001)
identified blood mercury levels of 1.0 mg/mL to be
the lowest level causing symptoms of toxicity upon
exposure to ethyl mercury, with higher levels showing
severe symptoms. The highest concentration (5 mM)
used in our studies is consistent with the lowest toxic
mercury level identified by Magos. However, while
the concentrations in our studies were slightly higher
than those seen by Pichichero et al. (2002) at 328
days following vaccination, they may more closely
reflect the exposure levels immediately following
vaccination.
DTD 5
Fluorescent Microscopy
MTT
Cells were seeded in a 96-well flat-bottom plate at
a density of 4 104 cells per well in 100 mL of
medium. After 24 h, thimerosal-containing medium
was added to the cells with final concentrations of 1
5 mM in a total volume of 200 mL. Cells were treated
in replicates of five wells each for every experiment
(6 experiments total), with medium used as a blank.
Cells were treated for either 24 or 48 h. 3-(4,5dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was prepared by dissolving 5 mg/mL in
PBS (pH 7.4) and then sterile filtered. Four hours
before the end of the incubation period 10 mL of
MTT was added to each well. At the end of the
treatment period, 100 mL of 0.1 N isopropanol/HCl
was added to each well and mixed by repeated
pipetting to dissolve granules. Absorbance was measured on a plate reader (Molecular Devices Corp.,
Sunnyvale, CA) at a wavelength of 570 nm (Mosmann, 1983). Results were reported as percentage of
control.
LDH
Cells were seeded in 2 mL of medium in 6-well
plates. At 8090% confluency, cells were treated with
the following concentrations of thimerosal in replicates of three: 0.1, 1, 2.5, and 5 mM. Cells were
incubated for 24 or 48 h, followed by removal of
medium and centrifugation to pellet floating cells.
The supernatant was removed and placed in a separate tube on ice. Five hundred microliters of 0.2%
Triton X was added to each well, and cells were
scraped and added to the cells pelleted from the
medium. Each well was washed with 500 mL of
water, which was also added to the tube with the
cells. The tubes were vortexed for 1 min, centrifuged,
and placed on ice. b-NADH solution was prepared by
dissolving 2 mg b-NADH in 28.5 mL of 0.1 M potassium phosphate buffer. Fifty microliters of sample
was added to 920 mL b-NADH solution and incubated at room temperature for 20 min. After incubation, 30 mL sodium pyruvate solution was added and
the absorbance was read at a wavelength of 340 nm at
25 8C. Readings were taken every 15 s for 2 min to
determine the absorbance change per min, which was
used to calculate LDH activity with the following
equation: LDH activity (mmol/L) = dA/min/6.22/
DTD 5
Subcellular Fractionation
The mitochondrial fraction of SK-N-SH cells was
prepared by washing the cells twice in ice-cold PBS,
followed by resuspension in 5 mL of 0.25 M sucrose,
1 mM EGTA, and 10 mM Tris-HCl (pH 7.4) and
centrifuging at 500 g for 2 min at 4 8C. The supernatant was discarded and the cells were resuspended in
5 mL of the same buffer. The cells were homogenized
in a glass Teflon homogenizer with 10 up-and-down
strokes at 500 rpm. The homogenate was centrifuged at
1500 g for 10 min at 4 8C. The supernatant was
removed and recentrifuged at 10,000 g for 10 min.
The pellet, which contained mitochondria, was resuspended in 50 mL of buffer. The supernatant was recentrifuged at 100,000 g (4 8C, 1 h) to generate the S100 fraction. Protein concentration of both fractions
was determined by a colorimetric assay (Bio-Rad
Laboratories, Hercules, CA).
Western Analysis
All Western analysis experiments were performed at
least three times, with a representative figure shown.
centrifuged (12,879 g) for 3 min and then the supernatants were stored at 70 8C. The protein concentration was determined as described previously. One
hundred micrograms of total cell lysate was resolved
on a 12.5% SDS-PAGE, transferred to nitrocellulose,
and probed with either an affinity-purified rabbit polyclonal antibody raised against a recombinant protein
corresponding to amino acids 315397 mapping within
the carboxy terminus of human caspase 9 (1:1000; Santa
Cruz Biotechnology) or a polyclonal antibody raised
against a synthetic peptide corresponding to residues
surrounding the cleavage site of human caspase 3
(1:1000, Cell Signaling Technology; Beverly, MA).
PARP
Thimerosal-induced apoptosis was examined by
proteolytic cleavage of PARP. One hundred fifty micrograms of nuclear-extracted proteins was loaded and ran
on a 7% SDS-PAGE. The membrane was incubated
with a goat anti-PARP antibody (1:1000; Cell Signaling Technology) raised against a KLH-coupled synthetic peptide mapping at the caspase cleavage site of
poly (ADP-ribose) polymerase.
Statistical Analysis
Cytochrome c
Either 20 mg of mitochondrial proteins or 40 mg of
S-100 fractionated proteins were loaded on a 12.5%
SDS-PAGE (SDS-polyacrylamide gel electrophoresis)
according to the method of Laemmli (1970) and transferred to nitrocellulose. Transfer onto nitrocellulose
membrane was assessed by incubating with 0.1%
Ponceau. The membrane was washed with distilled
water to remove the excess stain and blocked in Blotto
[5% milk, 10 mM Tris-HCl, 150 mM NaCl (pH 8.0),
and 0.05% Tween-20] for 1 h at room temperature. A
monoclonal antibody purchased from PharMingen
(San Diego, CA) was used at a final concentration
of 1 mg/mL. After two washings in TBS (10 mM TrisHCl and 150 mM NaCl)-0.05% Tween-20, the blot was
incubated with an anti-mouse IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Santa
Cruz, CA) at a 1:5000 dilution in Blotto for 1.5 h at
room temperature. The blot was washed three times
with TBS-0.05% Tween-20 (TBST) and once with
TBS. Protein bands were visualized with the enhanced
chemiluminescence detection system (ECL, Amersham, Little Chalfont, U.K.).
Caspase 9 and Caspase 3
Cells were washed in PBS and solubilized in lysis
buffer (Clontech) for 10 min on ice. Samples were
RESULTS
Morphological Changes upon Thimerosal
Treatment
In order to determine if thimerosal induced toxicity
in human neuroblastoma, cells (SK-N-SH) were treated with a range of thimerosal concentrations (0
5 mM), visualized and photographed with a Nikon
Phase Contrast microscope. Thiosalicylate (5 mM)
was used as the control in this and all subsequent
experiments. Within 2 h of exposure to thimerosal,
membrane alterations could be visualized, followed
by cell shrinkage and detachment (Fig. 1). Observed
morphological changes upon thimerosal administration were consistent with reports of mercurialmediated cytoskeletal toxicity (Duhr et al., 1993;
Kinoshita et al., 1999). In this model, we showed
cytoskeletal changes at concentrations of thimerosal
significantly below those previously reported by Kim
et al. (2002) in treatment of HeLa S cells (20 mM).
DTD 5
Fig. 1. Morphological analysis of SK-N-SH cells following treatment with either (A) 5 mM thiosalicylate for 6 h; (B) 5 mM thimerosal for 2 h; (C) 5 mM
thimerosal for 4 h and (D) 5 mM thimerosal for 6 h. No changes in morphology were noted in the thiosalicylate treated cells, whereas thimerosal caused
alterations of membranes (arrow), characteristic of cellular blebbing seen in apoptosis. In addition, cell shrinkage and detachment occurred within 6 h of
treatment. Cells were visualized and photographed using a Nikon Phase Contrast Microscope.
LDH Assay
To further evaluate toxicity, activity of lactate dehydrogenase (LDH), a cytosolic enzyme released into
surrounding media during cell death, was measured. As
the membrane loses integrity during necrosis and late
apoptosis, LDH is released. This assay approximates
cell death rates by measuring enzymatic activity of
LDH as it converts pyruvate and NADH to lactate and
NAD (Loo and Rillema, 1998). The LDH assay indicated a concentration- and time-dependent thimerosalinduced toxicity. At 24 h, LDH activity was significantly higher ( p < 0.001) than control at 2.5 and 5 mM
thimerosal treatments, indicating a loss of membrane
integrity (Fig. 2). Extending the exposure time to 48 h
showed a significant increase in LDH activity with
1 mM thimerosal, as well (Fig. 2).
MTT Assay
The MTT assay is a colorimetric assay for cytotoxicity. MTT is cleaved to a blue formazan product by
dehydrogenase enzymes of intact mitochondria, allowing for determination of cell viability (Mosmann,
1983). As with the LDH assay, thimerosal treatment
induced toxicity in a concentration- and time-dependent manner in SK-N-SH cells. At 24 h, cell viability
was significantly decreased with 5 mM thimerosal in
comparison to the control (Fig. 3). At 48 h, cell via-
DTD 5
DTD 5
Fig. 7. A: Caspase 3, a downstream target of caspase 9, is cleaved to a 17 and 19 kDa fragment upon activation. At 24 h both cleavage products were detected in
cells treated with 5 mM thimerosal. Although cleavage products were not detectable until 24 h following treatment, caspase 3 activity was elevated within 6 h in
cells receiving 5 mM thimerosal (7B). With the ApoAlert fluorescence detection assay, caspase 3 activity was increased in both 1 and 5 mM thimerosal receiving
cells after 24 h; however, those receiving 1 mM showed a lower caspase activation.
DTD 5
DISCUSSION
In the current study we demonstrate a role for
mitochondria in thimerosal-induced apoptosis in the
human neuroblastoma cell line, SK-N-SH. The model
was chosen due to cellular characteristics representative of those in an immature nervous system. The SKN-SH cell line, comprised of a neuroblast cell type,
retains the capacity to differentiate in vitro, rather than
representing a model of terminal differentiation. In
addition, neuroblastoma models have been reported
to be sensitive to mercurial toxicity (Sager and
Syversen, 1984; Stoiber et al., 2004; Toimela and Tahti,
2004). Several studies have indicated that both inorganic and organic mercurials induce apoptosis in vitro
as well as in vivo. Comparison studies of inorganic
(HgCl2) and organic mercurial (MeHgCl) toxicity have
been conducted in T lymphocytes. Findings suggest
that both types of mercurials disrupt mitochondrial
function, increase cellular oxidative stress and cause
apoptosis. However, the specific cell death pathway
(mitochondrial dependent versus independent) varies
with mercurial form (Guo et al., 1998; Shenker et al.,
1999, 2000); inorganic mercury induces apoptosis in a
mitochondrial
independent
manner,
whereas,
MeHgCl-mediated cell death is associated with cytochrome c mobilization.
Release of proapoptotic factors such as cytochrome c
and apoptosis inducing factor (AIF) are characteristics
of mitochondrial-mediated cell death. It has been well
established that release of cytochrome c from the mitochondria triggers the formation of a caspase 9 complex,
which recruits additional factors, including Apaf-1 and
ATP (Li et al., 1997). Collectively this complex has been
termed the apoptosome. Formation of the complex
leads to activation of caspase 9, which then processes
and activates other caspases, including caspase 3. In
contrast, release of AIF from mitochondria results in
caspase-independent cell death.
In the present study, exposure to thimerosal resulted
in an apoptotic cascade more closely resembling the
effects of organic mercurials than those of HgCl2. First,
we saw evidence of mitochondrial involvement as
thimerosal-treated cells showed release of cytochrome
c. Additionally, a concentration- and time-dependent
loss of mitochondrial viability was observed with the
MTT assay. Release of cytochrome c was followed by
cleavage of caspase 9. This is the first study to identify
caspase 9 as a component of mercurial-induced cell
death, and more specifically that of thimerosal exposure. The reactivity of Hg with sulfhydryl groups is
thought to occur nonspecifically; however, in this
model we show selectivity in regard to caspase activation, with thimerosal specifically activating the mitochondrial caspase 9 pathway, without activating
mitochondrial-independent caspase 8.
We next saw an increase in caspase 3 cleavage at
24 h with 5 mM thimerosal treatment. With the ApoAlert assay, which is more sensitive than Western blotting, an increase in caspase 3 activity was seen as early
as 6 h with the same treatment. Evidence of the activation of the apoptotic cascade at this earlier time point is
consistent with the morphological changes observed in
the SK-N-SH cells; phase contrast microscopy
revealed membrane alterations, cell shrinkage, and
detachment beginning to occur within this time frame.
By 24 h, as seen by fluorescence microscopy, apoptotic
cells were numerous, but some cells also exhibited a
loss of membrane integrity, as evidenced by the uptake
of ethidium bromide. This loss of membrane integrity,
which is confirmed with the LDH studies, is most
frequently associated with oncosis/necrosis. However,
Baskin et al. (2003) suggests that these membrane
changes may not be a necrotic process, but may be
caused by a direct effect of thimerosal on the cell
membrane itself. Furthermore, Baskin et al. (2003)
suggests that free radicals may be involved in thimerosal-induced damage to the cell membrane.
Inorganic and organic mercurials, including thimerosal, have been shown to increase reactive oxygen
species (ROS) and induce a state of oxidative stress
in numerous cell types; however, it is unknown whether
this is a direct effect of the metal. Studies have shown
that thimerosal causes release of calcium from intracellular stores followed by an influx of extracellular
calcium (Gericke et al., 1993; Elferink, 1999), which
can lead to an increase in reactive oxygen and nitrogen
species (RNS) production in the mitochondria. Both
ROS and RNS have been shown to cause apoptotic cell
death (McGowan et al., 1996; Szabo, 1996; Cai and
Jones, 1998; Chung et al., 2001). Reactive oxygen
species and RNS can directly interact with macromolecules such as proteins and nucleic acids, leading to
perturbations of vital cellular functions which may
result in cell death. Additionally, Brawer et al.
(1998) reported mitochondrial accumulation of iron
in astrocytes cultured with HgCl2. LeBel et al. (1992)
reported that pretreatment with the iron chelator deferoxamine inhibited Hg-induced generation of ROS in
the brain. Taken together these studies suggest a role
for iron-catalyzed ROS production within mitochondria of mercury-exposed tissues.
Finally, in our studies we see a differential processing of PARP. Processing of PARP by cysteine pro-
DTD 5
ACKNOWLEDGEMENTS
This work was supported by the National Institutes
of Health Grant R15, ES12209-01, to Dr. Kelley
Kiningham. Marsha P. Cole is the recipient of a training
grant (DK07778-02) in the Graduate Center for Nutritional Sciences at the University of Kentucky. The
authors wish to thank Kris Grimes, Brittany Ray and
Carla Cook for technical contributions to the manuscript, as well as Dr. Daret St. Clair for helpful suggestions in preparation of the manuscript.
REFERENCES
Aschner M, Aschner JL. Mercury neurotoxicity: mechanisms of
blood-brain barrier transport. Neurosci Biobehav Rev
1990;14(2):16976.
Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in
childhood vaccines. Pediatrics 2001;107(5):114754.
Baskin DS, Ngo H, Didenko VV. Thimerosal induces DNA breaks,
caspase-3 activation, membrane damage, and cell death in
cultured human neurons and fibroblasts. Toxicol Sci
2003;74(2):3618.
Blair AMJN, Clark B, Clarke AJ, Wood P. Tissue concentrations of
mercury after chronic dosing of squirrel monkeys with thiomersal. Toxicology 1975;3(2):1716.
Brawer JR, McCarthy GF, Gornitsky M, Frankel D, Mehindate K,
Schipper HM. Mercuric chloride induces a stress response in
DTD 5
10